Summit Therapeutics, Inc. (SMMT)
15.94
+0.07
(+0.44%)
USD |
NASDAQ |
Feb 20, 16:00
15.74
-0.20
(-1.25%)
After-Hours: 20:00
Summit Therapeutics Total Assets (Quarterly) : 261.73M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 112.48B |
| Exelixis, Inc. | 2.882B |
| Insmed, Inc. | 2.265B |
| Madrigal Pharmaceuticals, Inc. | 1.260B |
| Soleno Therapeutics, Inc. | 599.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 69.47M |
| Shareholders Equity (Quarterly) | 192.26M |
| Debt to Equity Ratio | 0.0282 |
| Current Ratio | 3.796 |
| Net Debt Paydown Yield | 0.13% |